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ABSTRACT The emergence of the disease chytridiomycosis caused by the chytrid fungus Batrachochy-
trium dendrobatidis (Bd) has been implicated in dramatic global amphibian declines. Although many
species have undergone catastrophic declines and/or extinctions, others appear to be unaffected or persist
at reduced frequencies after Bd outbreaks. The reasons behind this variance in disease outcomes are poorly
understood: differences in host immune responses have been proposed, yet previous studies suggest a lack
of robust immune responses to Bd in susceptible species. Here, we sequenced transcriptomes from clutch-
mates of a highly susceptible amphibian, Atelopus zeteki, with different infection histories. We found
signiﬁcant changes in expression of numerous genes involved in innate and inﬂammatory responses in
infected frogs despite high susceptibility to chytridiomycosis. We show evidence of acquired immune
responses generated against Bd, including increased expression of immunoglobulins and major histocom-
patibility complex genes. In addition, fungal-killing genes had signiﬁcantly greater expression in frogs
previously exposed to Bd compared with Bd-naïve frogs, including chitinase and serine-type proteases.
However, our results appear to conﬁrm recent in vitro evidence of immune suppression by Bd, demon-
strated by decreased expression of lymphocyte genes in the spleen of infected compared with control
frogs. We propose susceptibility to chytridiomycosis is not due to lack of Bd-speciﬁc immune responses but
instead is caused by failure of those responses to be effective. Ineffective immune pathway activation and
timing of antibody production are discussed as potential mechanisms. However, in light of our ﬁndings,
suppression of key immune responses by Bd is likely an important factor in the lethality of this fungus.
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Emerging infectious diseases arising from wildlife are rapidly gain-
ing public and media attention as signiﬁcant global threats to spe-
cies diversity, ecosystem function, and human health (Chomel et al.
2007; Daszak et al. 2000; Fisher et al. 2012; Jones et al. 2008). Emerg-
ing diseases can have dire consequences for wildlife populations them-
selves and are now recognized as important drivers of species declines
and extinctions (Smith et al. 2009). An emerging pathogen’s ability to
“jump” between or infect multiple host species may be key to their
rapid spread in natural populations (Altizer et al. 2011; Dobson 2004),
but it is the variance in host-speciﬁc immune capabilities to cope with
infection that leads to pathogen persistence in populations, as some
hosts act as reservoirs for the disease in multihost communities
(Cronin et al. 2010; Haydon et al. 2002). Therefore, evaluating var-
iation in the function and efﬁcacy of host immune responses to
emerging pathogens is essential for understanding how new diseases
may spread and establish in both animal and human populations.
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Amphibians are experiencing global declines of unprecedented
proportions; up to 50% of all species are currently at risk, making
them the world’s most threatened class of vertebrates (Fisher et al.
2009b). The emergence of the fungal pathogen Batrachochytrium den-
drobatidis (Bd) is one of the main forces driving these enigmatic
declines (Lips 1999; Lips et al. 2006; Skerratt et al. 2007), especially
in tropical highlands, where amphibian species diversity is greatest
(Duellman 1999). Bd colonizes host skin and causes the disease chy-
tridiomycosis, signs of which include lethargy, lack of appetite, cuta-
neous erythema, irregular skin sloughing, abnormal posture, loss of
righting reﬂex, and eventually death in many species (Berger et al.
1998; Longcore et al. 1999; Voyles et al. 2011). Nonetheless, although
many species have undergone catastrophic declines and/or extinctions
upon arrival of Bd, some species appear to be unaffected or persist at
reduced frequencies after chytridiomycosis outbreaks (Brem and Lips
2008; Briggs et al. 2010; Lips 1999; Woodhams and Alford 2005). The
reasons behind such wide-ranging differences in disease outcomes,
even in sympatric species, are poorly understood. Differences in host
immune responses are one potential explanation (Rollins-Smith et al.
2002; Savage and Zamudio 2011; Woodhams et al. 2007). Anurans
possess immunogenomic architecture and cellular mechanisms of in-
nate and acquired immunity that are similar to those of mammals,
birds, reptiles, and, to some extent, ﬁshes (Du Pasquier et al. 1989;
Ohta et al. 2006). However, limited knowledge of amphibian immune
function has precluded a rigorous assessment of the mechanistic
underpinnings of variation in disease susceptibility.
As of yet, no clear consensus exists regarding how acquired and
innate immunity are involved in frog host responses to Bd. Empirical
evidence indicates that differences in ﬁrst line of immunological de-
fense, innate immunity, such as skin antimicrobial peptides (AMPs),
may contribute to variation in infection outcomes among hosts
(Woodhams et al. 2007). In addition, we know that inﬂammation
(Berger et al. 2005a) and inﬁltration of neutrophils and macrophages
(Nichols et al. 2001) can occur when the pathogen enters frog skin
cells. However, experimental infection challenges testing for sustained
acquired immune responses of frogs to Bd infections have produced
mixed results. Previous infection increases survival rates in some spe-
cies (Murphy et al. 2011) but not others (Cashins et al. 2013). In
addition, although inoculation with heat-killed Bd can elicit speciﬁc
antibody responses (Ramsey et al. 2010), immunization had no effect
on survival of two species tested (Rollins-Smith et al. 2009; Stice and
Briggs 2010). Moreover, transcriptomic studies of three susceptible
species purport a lack of robust immune responses (Rosenblum et al.
2009, 2012).
The variation in amphibian susceptibility to chytridiomycosis and
the apparent lack of strong immunogenetic responses to experimental
Bd challenges have led to the hypothesis that Bd can evade or suppress
host immune responses (Ribas et al. 2009; Rollins-Smith et al. 2011;
Rosenblum et al. 2008, 2009). Other fungal pathogens suppress or
evade host immunity through a variety of mechanisms, including:
(1) recognition avoidance by immune receptors via sequestration
within host cells (Woods 2003); (2) digestion of its own antigens with
metalloproteases to avoid recognition (Hung et al. 2005); and (3)
interference with immune signaling (Brandhorst et al. 2004). Recent
in vitro experiments have shown that Bd impairs splenic lymphocyte
proliferation and induces apoptosis (Fites et al. 2013). However, these
ﬁndings have not been demonstrated in vivo or in a species demon-
strating Bd susceptibility in nature, and further studies are needed to
assess whether this lymphocyte-killing mechanism contributes to host
variation in susceptibility.
In this study, we exposed adults of the Panama Golden Frog
(Atelopus zeteki, Figure 1A) with different infection histories (Bd-naïve
and previously infected with an attenuated Bd strain) to Bd and com-
pared their transcriptome-wide gene expression in three immunologi-
cally important tissues with that of uninfected control individuals.
A. zeteki was chosen due to its high susceptibility to chytridiomycosis,
Figure 1 Number of signiﬁcant differentially expressed
genes among Atelopus zeteki tissues and infection
groups. Area-proportional Venn diagrams summarizing
the number of signiﬁcantly differently expressed genes
(,0.05 FDR corrected P value) of (A) Atelopus zeteki, (B)
among three tissues, and (C) among treatment groups
within each tissue. Photo courtesy of Brian Gratwicke.
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which is largely responsible for the near-extinction of this species in the
wild (Gewin 2008). This critically endangered frog, and other species
within the genus Atelopus, have become a ﬂagship for public awareness
to the plight of amphibians in the face of the spread of Bd and the
species is the focus of an intensive captive-breeding program (Blaustein
and Dobson 2006; Gewin 2008). Our objectives were twofold: (1) char-
acterize transcriptomic changes related to immune responses of
A. zeteki to Bd and (2) ascertain whether there is functional genomic
evidence of Bd suppression of immune functions contributing to the
high susceptibility of this species.
MATERIALS AND METHODS
Experimental infections
Ten captive-bred adult (approximately 18-mo-old) Atelopus zeteki
from the same clutch of a full-sibling mating at the Maryland Zoo
in Baltimore were used for experiments. These animals were surplus
to the Golden Frog Project captive breeding program at Maryland
Zoo. We chose full siblings for our experiment because genetic poly-
morphisms may account for a substantial proportion of variation in
gene expression (Stranger et al. 2007) and biological variation in small
sample sizes can hinder the ability to detect meaningful differences in
gene expression between treatment groups (Hansen et al. 2011). Dif-
ferential gene expression studies using related individuals also pose
limitations as the transcriptomic response of one genetic lineage may
not hold for the entire species. However, as this species is critically
endangered and therefore availability of experimental animals is lim-
ited, we opted to reduce genetic diversity due to small available sample
sizes.
All individuals had no previous exposure to Bd, appeared healthy,
and tested negative for Bd at the start of the experiment. Individuals
were paired by weights and placed into one of two treatment groups;
control and naïve-infected. Two additional frogs from the same clutch,
previously exposed to Bd strain JEL-427-P39 (30 mL of 1 · 102
zoospores/mL) but which survived Bd infections (i.e., developed sub-
stantial Bd loads yet survived with reduced infection without inter-
vention), were assigned as a third, survived-infected, treatment group
(Langhammer et al. 2013).
Animals in all three treatments were housed individually in
sphagnum-moss ﬁlled plastic shoeboxes with a water dish, in a lab-
oratory maintained at 21-22 with a 12:12-hr light:dark photoperiod. All
housing materials were replaced every 7 d, water dishes changed every
3 d, and animals were fed three to four crickets or 10215 fruit ﬂies
(Drosophila melanogaster) sprinkled with Herptivite (Rep-Cal Research
Labs) every 3 d.
For experimental infections we used Bd strain JEL-423 cultured
and cryopreserved from a ﬁeld-infected Hylomantis lemur, during the
epidemic outbreak at El Copé, Panama in 2004 (Lips et al. 2006). A
hemocytometer was used to create a solution containing 1 · 103
zoospores/mL. The infection treatment frogs (ﬁve naïve, two survived)
were individually exposed to 30 mL of the Bd solution (30,000 zoo-
spores) in deli containers for 10 hr. The ﬁve control individuals were
exposed to a sham solution of distilled water and tryptone. Although it
is unknown whether our inoculation dose reﬂects exposure levels in
nature, earlier studies show that Bd-dose does not affect infection
likelihood or mortality but does inﬂuence time to death (Carey
et al. 2006). Both JEL-423 and JEL-429 strains belong to the hyper-
virulent global pandemic lineage of Bd (Farrer et al. 2011).
Throughout the experiment, we used a fresh pair of latex powder-
free gloves when handling each individual. All individuals were as-
sayed for Bd infection status and load at day 8 postinoculation, and
thereafter every 324 d. We swabbed the abdomen, drink patch, hands,
and feet ﬁve times each with a sterile cotton tipped swab, which was
then stored in capped tubes containing 30 mL of 70% ethanol (Hyatt
et al. 2007). We tested swabs for Bd using PrepMan Ultra and ran
samples in singlicate Taqman quantitative polymerase chain reaction
(qPCR) (Boyle et al. 2004). We ran each plate with JEL-427 standards
of 0.1, 1, 10, 100, and 1000 zoospore genomic equivalents to determine
Bd presence and infection intensity. We categorized individuals as
Bd-positive when qPCR results showed an infection load greater than
or equal to one Bd zoospore genomic equivalent (Kriger et al. 2006).
Individuals were monitored daily for clinical symptoms of chytridio-
mycosis, and we killed those that had lost righting abilities by applying
20% Benzocaine to the venter. All individuals were sexed, weighed, and
measured at the end of the experiment. Control animals were killed
on day 33, the day the last infected individual was killed. The number
of Bd zoospores that infect an individual during inoculation is variable
and can cause variations in length of time to death among individuals
(Carey et al. 2006). Thus, we harvested tissues when all individuals
were biologically experiencing the same clinical signs of chytridiomy-
cosis, rather than choosing a ﬁxed time point when individuals vary in
disease progression. Immediately after euthanasia, frogs were dissected
using sterilized instruments, and skin (drink patch), spleen, and small
intestine tissue samples were harvested from each individual. These
tissues were chosen as (1) skin is the primary site of infection for
Bd (Longcore et al. 1999), (2) the spleen is the major lymphoid organ
in frogs, involved in producing leukocytes and other immune cells
(Tischendorf 1985), and (3) small intestine has been shown to possess
large numbers of B cells and expresses T-cell2independent immu-
noglobulins in other anuran amphibians (Mußmann et al. 1996). Tissue
samples were immediately placed in RNALater (Invitrogen) and stored
at 280 prior to RNA extraction and library preparation. All experi-
ments were performed with approval from and in accordance with the
ethical standards of the US Institutional Animal Care and Use Com-
mittee under protocol R-12-98.
Transcriptome sequencing
Total RNA was extracted from each tissue sample separately using
RNAdvance tissue kit (Beckman Coulter Inc.). We quantiﬁed and
assessed RNA integrity using a 2100 Bioanalyzer total RNA nano
assay (Agilent Technologies). All samples had RNA integrity values
greater than 8.0. Libraries were generated using the Illumina TruSeq
RNA sample preparation kit v2 (low-throughput protocol) according
to the manufacturer’s instructions (Illumina, San Diego, CA). Brieﬂy,
0.421.2 mg of RNA was subjected to mRNA selection using poly-T
oligo-attached magnetic beads followed by chemical fragmentation
(6 min, 94). The cleaved RNA fragments were then copied into
ﬁrst-strand cDNA using SuperScript II reverse transcriptase (Invitro-
gen) and Illumina proprietary random hexamer primers. After sec-
ond-strand synthesis using Illumina supplied consumables, the cDNA
was ampliﬁed with reagents of the same kit and ligated to barcoded
adapters. The ﬁnal libraries were ampliﬁed using 14 PCR cycles. We
quantiﬁed and assessed library quality on a Bioanalyzer 2100 and
randomly pooled equimolar samples in four lanes of the Illumina
ﬂowcell (eight or nine samples per lane).
Transcriptome assembly and functional annotation
After Illumina standard quality control ﬁltering, read quality for each
sample was visualized using FastQC version 0.10.0 (Andrews 2010).
All samples had greater than average GC content in the ﬁrst 15 bp due
to utilization of random hexamer primers during library preparation.
Therefore we used Trimmomatic version 0.27 (Lohse et al. 2012) to;
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(1) remove the ﬁrst 15 bp of each read, (2) trim any Illumina adapter
sequence, (3) trim the 59 and/or 39 end of reads where quality score
dropped below Q20, (4) trim anywhere within each read where a 5-bp
window drops below Q20, and (5) discard any trimmed reads less
than 36 bp long. This ensured only the highest quality reads were used
for subsequent de novo assembly.
Reads from all individuals and tissues were pooled to assemble
a consensus transcriptome. To overcome the challenges associated
with high memory and computing requirements necessary for de novo
assembly of large numbers of sequence reads, we performed Trinity
(Grabherr et al. 2011) in silico read normalization procedure before
assembly. Assembly was performed using Trinity’s default parameter
settings on a high-performance cluster with 64 CPUs and 512GB
RAM. We ﬁltered out transcripts with expression support of less than
ﬁve reads per million mappable reads in at least two samples to
eliminate low-level expression noise (Harrison et al. 2012; Moghadam
et al. 2013).
Blast2GO version 2.5.0 (www.blast2go.com) was used to function-
ally annotate the assembled transcriptome. First, the longest sequence
of each Trinity component (roughly equivalent to a single gene) was
extracted from the assembly using custom Perl scripts. Next, these
sequences (hereafter contigs) were aligned via Blastx to the National
Center for Biotechnology Information (NCBI) nonredundant protein
database, retaining up to 20 hits with a minimum E-value of 1 · 1026
and minimum bit score of 55. Any contig aligning to the Bd tran-
scriptome (Batrachochytrium dendrobatidis Sequencing Project, Broad
Institute of Harvard and MIT; www.broadinstitute.org) was removed
from further analyses. Gene ontology (GO; www.geneontology.org)
mapping was performed by extracting the GO terms associated with
homologies identiﬁed by Blastx and producing a list of GO annota-
tions represented as hierarchical categories of increasing speciﬁcity.
We retained annotations with a minimum E-value of 1 · 10206,
a minimum annotation cut-off of 55, and a GO weight of 5. GO
annotations were enhanced using the annotation augmentation
tool ANNEX (Myhre et al. 2006). Finally, we performed InterPro
(Quevillon et al. 2005) searches remotely from BLAST2GO via the
InterPro EBI web server and merged InterProScan GOs with the
original GO annotations.
Gene expression analysis
We analyzed differential gene expression (DE) using the edgeR
(Robinson et al. 2010) R package (R version 2.15.2, R Development
Core Team). Analysis in edgeR consisted of (1) only including contigs
with more than ﬁve counts per million from at least two individuals;
(2) estimating tagwise dispersion and normalization factors; and then
(3) DE was tested using the exact test and the false-discovery rate
(FDR) corrected P-value of less than 0.05 was considered to be evi-
dence of DE. PowerAtlas (Page et al. 2006) analysis of raw P-values
showed that comparisons using the smallest treatment group (survived-
infected, n = 2) would correctly identify ~85% of truly differentially
expressed genes and ~76% of truly nonsigniﬁcant genes. Thus,
after correction for multiple testing, our lists of differentially ex-
pressed genes are highly conservative but necessary given our
small sample sizes. To get a broad overview of DE patterns within
each tissue type, highly differentially expressed genes (,0.001
FDR, .fourfold change) were clustered via a k-means algorithm
and plotted on heatmaps using Trinity-provided and custom Perl
and R scripts. GO functional enrichment tests (with FDR correction
for multiple tests) were carried out on each cluster via Blast2GO to
detect signiﬁcantly overrepresented biological processes, molecular
functions, and cellular components.
RESULTS
Experimental infections
Experimental animals consisted of 1 male (control group) and 11
females. Despite the potential for sex differences in gene expression
levels, subsequent analyses including and excluding the male control
animal were not substantially different from one another. Over-
all expression patterns and speciﬁc genes found to be signiﬁcantly
different between control and infected groups remained consistent,
albeit with minor differences in fold-change and signiﬁcance values.
Therefore, we included all individuals, regardless of sex, in our
analyses. Weight and snout-to-vent length of the treatment groups did
not differ signiﬁcantly at the start of the experiment (weight; F2,8 =
0.222, P = 0.806, length; F2,8 = 0.030 P = 0.971). All of the ﬁve control
animals remained Bd-negative for the duration of the experiment. All
infected animals (ﬁve naïve-infected, two survived-infected) were pos-
itive for Bd zoospores 8 d postinoculation (mean zoospores = 34,015,
S.E. = 15,741) and for the remainder of the experiment. One naïve-
infected individual died before being killed; therefore, that individual
was removed from the study. The remaining six infected frogs lost
righting reﬂexes and were killed between 22 and 33 days postinocu-
lation. Mean zoospore load at death for experimentally infected ani-
mals was 6,819,500 (S.E. = 2,431,929). No signiﬁcant differences in
survival time (t = 0.594, P = 0.585) or infection intensities (t = 1.896,
P = 0.106) were found between naïve-infected and survived-infected
animals. However, with only two individuals in the clear-infected
category, we cannot completely rule out the possibility that previous
exposure affects survival time or infection load in the species.
Transcriptome assembly and annotation
Skin, spleen, and small intestine tissue samples from 11 Atelopus zeteki
(ﬁve uninfected control, four naïve infected, and two survived in-
fected) were sequenced on four lanes of Illumina HiSeq, resulting
in more than 896 million 100 bp single-end reads in total. Sequences
are deposited in the NCBI Short Read Archive under the submission
accession number SRP029154. The average number of raw reads per
sample was approximately 27.2 million, reduced to 25.9 million after
quality ﬁltering and trimming. Total number of ﬁltered reads, pooled
from all samples and after normalization, was approximately 66.5
million. These were assembled using Trinity, and our de novo assem-
bly of the transcriptome yielded 447,764 transcripts, with a mean
length of 786 bp and N50 length of 1596 bp. After ﬁltering out low
expression transcripts by setting a threshold of at least ﬁve reads per
million mappable reads in at least two samples, we retained 116,504
transcripts, representing 40,084 expressed gene fragments and their
isoforms. We expect that the vast number of minimally expressed
contigs that fall below our threshold to largely represent transcrip-
tional errors such as intron expression, exon chimeras, and sequenc-
ing and assembly errors common to current de novo assembly
techniques (Moghadam et al. 2013). Of the assembled genes, 15,252
(38.1%) had at least one signiﬁcant hit against the nonredundant
NCBI protein database, and of these, 12,056 (79.0%) were successfully
annotated with GO terms. The vast majority—just over 72%—of best
hits were to Xenopus species.
Broad-scale patterns of gene expression
As expected, a signiﬁcant proportion of genes were differentially
expressed among the three tissue types, regardless of infection status
(Figure 1B). Within each tissue type, we identiﬁed a large number of
genes differentially expressed between the control (uninfected) frogs
and both infected groups (Figure 1C). However, far fewer genes were
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differentially expressed between naïve-infected and survived-infected
individuals (Figure 1C).
Clustering of skin gene expression patterns revealed four clusters
(SK1 to SK4, Figure 2A). SK1 and SK3 could be broadly characterized as
increased expression in infected frogs (more so in the naïve group) and
both had an overrepresentation of immune system functions (Table 1).
These included terms such as “response to fungus” (GO:0009620), “in-
ﬂammatory response” (GO:0006954), and “humoral immune response
mediated by circulating immunoglobulin” (GO:0002455). The two
other skin clusters (SK2 and SK4) were signiﬁcantly enriched for terms
such as “water transport” (GO:0006833), “keratinocyte differentiation”
(GO:0030216), and “collagen ﬁbril organization” (GO:0030199) and
generally exhibited decreased expression in the infected groups.
Spleen gene expression clusters totaled six (SP12SP6, Figure 2B)
and all but one (SP2) possessed signiﬁcantly overrepresented GO terms
(Table 1). Of note, SP5 and SP6 indicated decreased expression of im-
mune system activation terms in both naïve- and survived-infected frogs,
speciﬁcally in both alpha-beta and gamma-delta T-cell activation and
differentiation (GO:0046629, GO:0042492, GO:0046631, GO:0046632).
In addition, SP3, a small but extremely highly expressed set of genes in
the survived-infected frogs were enriched for “serine-type endopeptidase
activity” (GO:0004252), “metallocarboxypeptidase activity” (GO:0004181),
and “hydrolase activity” (GO:0016787). The SP3 gene cluster also in-
cluded massively increased expression of protease inhibitors (e.g., serpin
I2, log2-fold-change = 12.86, P = 2.04 E-100) in survived-infected frogs.
Expression clustering of intestine tissues revealed six clusters
(I12I6, Figure 2C), of which four were signiﬁcantly enriched for GO
terms (I1, I2, I5, I6; Table 1). One cluster exhibiting substantial
increases in expression in infected groups (I1), similar to SP3, con-
tained serine-type endopeptidase (GO:0004252) and metalloexopepti-
dase (GO:0008235) activity terms. In addition, I6 also showed minor
increases in expression, with overrepresented terms including “im-
mune system development” (GO:0002520) and “chronic inﬂamma-
tory response” (GO:0002544). Clusters I2 and I5 showed decreased
expression in infected individuals and were enriched for key metabolic
processes such as lipid and monosaccharide metabolism plus cell-cycle
components such as DNA replication and mitosis. Decreased expres-
sion of genes related to metabolic processes is likely a reﬂection of
reduced food intake, common during Bd infections. However, in con-
trast to skin and spleen samples, cluster expression differences be-
tween treatment groups were less deﬁned. For example, individuals
infected-1 and survived-1 showed expression patterns more similar to
controls than the other infected animals in the majority of the in-
testine clusters. The full list of signiﬁcantly enriched GO terms and
their P-values is provided in Supporting Information, Table S1.
Immune responses in Bd-infected frogs
We found 371 genes to be differentially expressed between infected
and control frogs that are identiﬁed as immunogenetic (Table S2,
Table S3, and Table S4). However, given the relative paucity of
Figure 2 Heatmaps summarizing differential gene ex-
pression in Atelopus zeteki. (A) skin, (B) spleen, and (C)
small intestine, clustered (via k-means clustering algo-
rithm) by similarity of expression. Each row represents
a gene within a minimum FDR-corrected P-value of
0.001 and at least fourfold difference in expression be-
tween samples (columns).
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amphibian immunological data, many genes discussed herein have
not yet been fully characterized in amphibians. It should be noted
that, given the stringent annotation criteria used, we are referring to
the most homologous genes and their functions in other vertebrates.
Within the great number of differentially expressed immune genes
found, the largest group could be broadly classiﬁed as encoding
n Table 1 Summary of gene cluster expression patterns and overrepresented GO terms
Clustera ID
Expression Patternb No. of Genes
(No. Annotated)
No. of Over
represented GO Terms Examples of Overrepresented GO TermscControld Naïvee Survivedf
Skin
SK1 21.1 +1.1 +0.5 1395 (654) 364 Response to fungus, humoral immune
response mediated by circulating
immunoglobulin,
B-cell activation involved in immune
response, cytokine secretion,
leukocyte migration
SK2 +2.4 22.7 20.7 129 (55) 13 Water transport, keratinocyte
differentiation, cellular response
to metal ion
SK3 +2.3 22.3 21.1 349 (172) 20 Inﬂammatory response, immune
response, defense response to
bacterium, response to
Lipopolysaccharide, response to
cytokine stimulus
SK4 +1.1 21.0 20.7 755 (475) 58 Epithelial cell proliferation, collagen
ﬁbril organization, electron transport,
DNA replication, heme
Catabolic process
Spleen
SP1 20.8 +1.1 20.1 373 (222) 8 Immune response, response to chemical
stimulus
SP2 20.6 20.2 +1.8 187 (104) 0 No signiﬁcant enrichment
SP3 21.5 21.5 +6.9 42 (39) 19 Proteolysis, serine-type endopeptidase
activity, metallocarboxypeptidase
activity, hydrolase activity
SP4 21.3 +1.2 +0.9 308 (168) 21 Cell communication, response to hypoxia,
circulatory system development, signaling
SP5 +1.6 21.5 21.2 108 (55) 64 Oxygen transport, immune system
development, cellular ion homeostasis,
Gamma-delta T-cell activation,
gamma-delta T-cell differentiation
SP6 +1.0 20.8 20.8 301 (166) 16 Alpha-beta T-cell differentiation, cytokine
production, regulation of cell activation,
hemopoiesis
Intestine
I1 21.8 +1.2 +2.2 23 (23) 23 Serine-type peptidase activity,
proteolysis, collagen catabolic
process, metalloexopeptidase activity
I2 +1.2 21.2 20.5 117 (76) 21 Oxidation-reduction process, lipid
metabolic process, monosaccharide
metabolic process
I3 +0.8 20.6 20.7 225 (93) 0 No signiﬁcant enrichment
I4 21.5 +1.6 +0.5 103 (53) 0 No signiﬁcant enrichment
I5 +0.9 20.7 20.9 152 (107) 57 Mitotic cell cycle, protein folding in
endoplasmic reticulum, DNA replication,
regulation of nuclease activity,
chromosome organization
I6 20.8 +1.0 0.0 234 (166) 58 Immune system development, programmed
cell death, regulation of response
to stress, chronic inﬂammatory
response, signal transduction
a
Clusters deﬁned by k-means clustering.
b
Average log2-fold change.c
Full list of overrepresented GO terms are provided in Table S1.
d
Control uninfected.
e
Bd-naïve infected.
f
Previously survived Bd infected.
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cytokine signaling molecules and their receptors. These included in-
creased expression of all major groups of cytokines that are part of the
vertebrate immune system; interferons, interleukins, tumor necrosis
factors, and chemokines (Table 2).
Genes encoding interleukins exhibited some of the greatest
increases in expression in infected animals, particularly in the skin.
Interleukin (IL)-10 and IL-17 both increased expression by greater
than 4000-fold in the skin of naïve-infected frog but was not signif-
icantly different between survived-infected and control animals (Table
S2). Signiﬁcant increases in IL-17 levels also were found in the spleen
of the naïve-infected but not in the survived-infected group (Table
S3). Inﬂammatory interleukins IL-1, -6, -8, -12, and -18 also were
found to have signiﬁcant increased expression in Bd-naïve frogs (Ta-
ble S2). However, all interleukins had either lower or nonsigniﬁcant
increases in expression in frogs previously exposed to Bd.
Many immune-related chemokines and their receptors showed
increased expression in skin, spleen, and intestine tissues of infected
frogs, including CCL4, CCL19, CCL27 CXCL10, CXCL14, CCR1,
CCR3, and CCR4 (Table 2). A number of components of the classical
complement system (e.g., C1q, C5) showed increased expression in all
three tissues studied (Table S2, Table S3, and Table S4), with the greatest
increases seen in the skin of naïve-infected frogs. Increased expression
was also found in the skin of survived-infected individuals, but to a lesser
extent in the spleen and intestine. Alternative pathway expression (e.g.,
complement factors b, d, h) in the spleen of infected animals is also
increased, but inconsistent patterns were observed in the skin and lower
expression levels than uninfected in the intestine. Infected A. zeteki
exhibited increased expression in seven TLR genes in at least one of
the three tissues studied (Table 2). TLR2 had moderately increased
expression in all tissues of the naïve-infected group (Table S2, Table
S3, and Table S4). TLR5 had the greatest increase in expression in all
tissues, particularly in the skin of naïve-infected frogs (Table S2).
The gene encoding the chitinase CHIT1 was found to have
signiﬁcant increases in expression in skin and spleen tissues in both
naïve-infected and survived-infected groups compared with the con-
trols (Figure 3). Expression increases were signiﬁcantly greater in the
spleen of survived-infected frogs compared with naïve-infected (with
a similar but nonsigniﬁcant trend in the skin). CHIT1 exhibited one of
the greatest expression changes of all genes in the spleen of survived-
infected individuals (greater than 99.6% of genes, Table S3).
Genes encoding receptors and other proteins speciﬁc to B cells
were found to have increased expression in both infected groups
within the skin and intestine, for example FC receptor 5-like (Table 2,
Table S2, and Table S4). Components of T-cell receptors (e.g., T-cell
receptor beta) and T-cell2speciﬁc CD markers such as CD4 and CD3
also were found to have elevated expression in the skin of infected
animals (Table 2 and Table S2). In addition, both class I and II MHC
genes showed signiﬁcant increases in expression in both naïve-
infected and survived-infected skin samples compared with uninfected
controls (Table 2 and Table S2). However, we found lower expression
levels in a number of B-cell2related genes, such as “B-cell lymphoma
leukemia 11b isoform 2,” in the spleen of both infected groups.
Markers speciﬁc to T cells such as CD4 and CD8 also were signiﬁ-
cantly lower in both naïve-infected and survived-infected spleens (Ta-
ble 3). In addition, a large number of T-cell receptor components were
also decreased in the spleen of infected individuals including alpha,
beta, gamma, and delta chains (Table 3).
Increased immunoglobulin expression was observed in all three
tissues of infected frogs. Although only a few contigs identiﬁed as
immunoglobulin-related had increased expression in intestine tissues,
16 were elevated in the spleen of naïve-infected frogs, many of which
were also found in survived-infected frogs (Table 2, Table S2, and
Table S4). In the skin, a substantial number were elevated in sur-
vived-infected compared with controls but not in naïve-infected animals
(Table S3). For example “immunoglobulin heavy chain constant region”
had greater expression levels in both infected groups compared with
controls in the spleen. But in the skin, this gene had similar expression
levels in uninfected and naïve-infected frogs yet signiﬁcantly increased
expression in survived-infected skin samples (Figure 4).
DISCUSSION
Broad-scale gene expression proﬁles of frogs infected
with Bd
Chytridiomycosis is one of the main drivers of the recent dramatic
declines in amphibian populations worldwide (Lips 1999; Lips et al.
2006; Skerratt et al. 2007). The efﬁcacy of species immune responses
to Batrachochytrium dendrobatidis—the causative agent of the disease—
is proposed to be a key factor in determining disease outcome
(Rollins-Smith et al. 2002; Savage and Zamudio 2011; Woodhams
et al. 2007). High-throughput methods of gene expression proﬁling,
such as RNA-Seq, provide the opportunity for in-depth characteriza-
tion of host responses and to elucidate important mechanisms in the
dynamics of this disease. Our transcriptome-wide study of a highly
susceptible species, Atelopus zeteki, identiﬁed a large number of genes
differentially expressed between the control (uninfected) frogs and
both infected groups. However, far fewer genes were differentially
expressed between naïve-infected and survived-infected individuals.
This ﬁnding suggests that broad-scale gene expression changes are
similar in frogs challenged by Bd regardless of their previous infection
history, and only a small subset of genes are differently expressed
among naïve and previously infected individuals. Of the three tissues
studied, the spleen, a major lymphoid organ of frogs, showed the
greatest dissimilarity in expression differences between naïve and
survived-infected frogs.
Although these results could be interpreted as indicative of
signiﬁcant changes in immunogenetic responses to infection due to
prior exposure, comparisons between Bd-naïve and Bd-survived
groups should be interpreted with degree of caution, given the small
sample size of the survived-infected group (n = 2). Small sample size
for individuals naturally surviving infection (i.e., without interventions
such as fungicidal treatment) was unavoidable for this study due to
this species’ high-susceptibility to Bd; only two of 60 frogs infected
with Bd survived the original experiment (Langhammer et al. 2013).
Despite the fact that frogs from both studies were highly inbred sib-
lings, we cannot infer from our data whether the transcriptomic
responses of the two surviving individuals are a result of innate genetic
predisposition or due to their previous exposure to a form of the
fungal pathogen. In addition, though reducing genetic variability by
utilizing clutch-mates can be beneﬁcial for small sample sizes (see
Materials and Methods), it may not fully capture the expression
responses of the entire species. Future infection studies should explore
attenuated (Langhammer et al. 2013) or naturally less virulent (Berger
et al. 2005b; Fisher et al. 2009a) Bd strains and in more genetically
diverse hosts as a means of obtaining greater sample sizes of cleared
individuals and to disentangle the effect of host genetics and previous
exposure on adaptive immunity.
Clustering of skin gene expression patterns revealed two sets of
genes, with signiﬁcantly greater expression in infected frogs, signiﬁ-
cantly enriched for many immune-related GO terms including in-
ﬂammatory, interleukin, B-cell, T-cell, and immunoglobulin responses.
This indicates that, in this species, there is increased expression
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of both innate and adaptive immune responses in skin cells, the
primary site of infection for Bd. The remaining skin clusters, with
overall decreased expression in infected individuals, included terms
involved in skin structure (e.g., collagen ﬁbril organization) and water
transport. These results are consistent with previous observations that
Bd pathogenicity occurs via disruption of skin integrity and water/ion
imbalance (Rosenblum et al. 2012; Voyles et al. 2009).
In the spleen, we found a small cluster of genes with large increases
in expression only in frogs previously exposed to Bd, which was
enriched for various protease GO terms and also included protease
n Table 2 Number of differentially expressed immune-related genes and percentage with expression increases in three tissues of
Atelopus zeteki
Category (Tissue)
Naïve vs. Control Survived vs. Control Naïve vs. Survived
No. % up No. % up No. % up
B cells
Skin 16 75.0 5 80.0 1 100.0
Spleen 18 38.9 15 40.0 1 100.0
Intestine 6 83.3 3 100.0 1 100.0
Complement
Skin 16 81.3 13 92.3 0 2
Spleen 16 100.0 7 100.0 2 50.0
Intestine 6 100.0 4 25.0 0 2
Immunoglobulins
Skin 8 75.0 9 88.9 4 0.0
Spleen 20 80.0 9 77.8 3 100.0
Intestine 3 100.0 1 100.0 0 2
Interferons
Skin 27 96.3 17 100.0 0 2
Spleen 17 35.3 22 18.2 0 2
Intestine 10 100.0 4 100.0 0 2
Interleukins
Skin 36 91.7 19 94.7 8 87.5
Spleen 24 70.8 11 36.4 4 100.0
Intestine 11 100.0 4 100.0 0 2
Macrophages
Skin 8 75.0 6 83.3 1 100.0
Spleen 10 80.0 5 40.0 2 100.0
Intestine 6 66.7 0 2 0 2
Major and minor histocompatibility
Skin 3 100.0 6 100.0 0 2
Spleen 3 33.3 4 75.0 0 2
Intestine 0 2 0 2 0 2
Nuclear factor-kb
Skin 6 100.0 4 100.0 0 2
Spleen 4 100.0 2 100.0 0 2
Intestine 2 100.0 1 0.0 0 2
Toll-like receptors
Skin 6 66.7 2 100.0 0 2
Spleen 6 100.0 3 33.3 1 100.0
Intestine 3 66.7 0 2 1 100.0
Tumor necrosis factors
Skin 28 92.9 17 100.0 3 100.0
Spleen 20 80.0 15 66.7 1 100.0
Intestine 16 87.5 7 71.4 0 2
T cells
Skin 8 75.0 3 33.3 0 2
Spleen 35 17.1 30 10.0 0 2
Intestine 4 50.0 1 0.0 0 2
Other cytokines
Skin 16 93.8 9 77.8 1 100.0
Spleen 18 72.2 12 41.7 4 75.0
Intestine 6 100.0 3 100.0 0 2
Other immune-related genes
Skin 22 90.9 16 87.5 3 66.7
Spleen 19 63.2 18 44.4 7 57.1
Intestine 12 75.0 6 100.0 2 100.0
A complete list of genes, fold-changes, and signiﬁcance is available in Table S2, Table S3, and Table S4. Control, uninfected control; naïve, Bd-naïve infected;
survived, previously survived Bd infected.
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inhibitors. Proteases, particularly serine peptidases, play important
roles in both invertebrate (Gorman and Paskewitz 2001) and vertebrate
innate immunity (Pham 2006; Steinhoff et al. 2005). Serine proteases
were found to be among the genes with the greatest increases in ex-
pression in Bd-infected Silurana tropicalis (Ribas et al. 2009). Con-
versely, they also are implicated as virulence factors for parasites
and pathogens, allowing them to invade or suppress host immune
systems (McKerrow et al. 2006). Indeed, Bd has expanded families
of both serine peptidase and metallopeptidase genes, which are
purported virulence factors in the fungus (Rosenblum et al. 2008).
Taken together, these results suggest host-protease activity and Bd-
protease inhibition could be crucial for dealing with Bd infections.
Clearly these classes of enzymes require further investigation, partic-
ularly in more resistant species, to more comprehensively understand
Bd pathogenicity and host species differences in susceptibility.
Innate defenses and interfaces of innate/
adaptive immunity
We identiﬁed more than 300 genes differentially expressed between
infected and control frogs that are identiﬁed as immunogenetic,
indicative of extensive immune and/or inﬂammatory responses to Bd
infection in Atelopus zeteki. These results are in stark contrast to
previous transcriptome studies of other Bd challenged susceptible
species, which showed an inconsistent or lack of robust immune re-
sponse to Bd infections (Rosenblum et al. 2009, 2012).
IL genes such as (homologs of) IL-10 and IL-17 exhibited some
of the greatest expression changes in infected frogs, particularly in
the skin. IL-10 is produced by helper T cells, functions in B-cell
maturation, and induces secretion of immunoglobulins (Rousset
et al. 1992). It is also an anti-inﬂammatory cytokine and down-
regulates Th2 cells and MHC class II antigens (de Vries 1995). In con-
trast, although also produced by helper T cells, IL-17 is proinﬂammatory
and induces the production of many other cytokine molecules (Kolls
and Lindén 2004). IL-1, -6, -8, -12, and -18 also were found to have
signiﬁcant increased expression in Bd-naïve frogs, all of which are
linked to inﬂammatory responses (Akdis et al. 2011). However, all
interleukins had either lower or nonsigniﬁcant increases in expression
in frogs previously exposed to Bd. Strong host inﬂammatory responses
to a pathogen can cause severe tissue damage and contribute signif-
icantly to the pathology of a disease (Graham et al. 2005; Sears et al.
2011). Our results suggest skin tissue inﬂammation is part of the
initial response to ﬁrst infection and may be an important factor in
the lethality of Bd infection in susceptible individuals. In addition, the
weaker inﬂammatory response in survived-infected animals could sug-
gest either (1) hosts with inherently weaker inﬂammatory responses
cope better with infection or (2) dampening of inﬂammation is an
acquired response due to prior exposure. Experimental modiﬁcation of
inﬂammatory responses in highly Bd-susceptible species could greatly
increase our understanding of levels of susceptibility to Bd in different
species or even within populations of a single species.
Figure 3 Differential gene expression of chitinase 1 in Atelopus zeteki. Results of exact tests for expression differences measured by fragments
per kilobases per million mapped (FPKM), in chitinase 1 gene in three tissues of Atelopus zeteki. Letters indicate signiﬁcant differences among
treatment groups (no signiﬁcant difference among groups with same letter, FDR corrected P-value ,0.05) and error bars represent 6 1 SE.
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The great number of cytokines identiﬁed involved in immune
signaling and regulation were predominantly more highly expressed
in all three tissues studied. A substantial proportion of those found in
the skin (e.g., CCL4, CCL19, CXCL10, CXCL14) are attractants for
antigen-presenting cells such as dendritic cells and macrophages,
which are thought to be key to initiating downstream acquired im-
mune responses to Bd (Richmond et al. 2009). Also of interest, CCL27
is associated with homing of memory T lymphocytes to the skin and
plays a role in T-cell2mediated inﬂammation of the skin (Homey
et al. 2002). Genes of the classical complement pathway were also
found to be more expressed in all tissues both infected treatment
groups. In contrast to our results, previous studies have detected
decreased expression of components of the classical complement path-
way (Rosenblum et al. 2009, 2012).
In theory, toll-like receptors (TLRs) should play a key role in
linking early innate responses to Bd to downstream acquired immu-
nity (Richmond et al. 2009) given their ability to recognize a variety of
other fungal pathogens in vertebrates (Luther and Ebel 2006; Roeder
et al. 2004). These evolutionarily conserved receptors recognize chem-
ical signatures in a wide variety of microorganisms, including fungi,
and are expressed by a number of cells involved in both innate and
acquired immunity (e.g., T and B cells, macrophages, and dendritic
cells). However, previous studies in other susceptible species found no
evidence for TLR activation during infection (Rosenblum et al. 2009,
n Table 3 T -cell receptor gene expression differences
Contig ID Description
Log2-Fold Change (FDR P-Value)
Naïve Infected Survived Infected
Skin Spleen Intestine Skin Spleen Intestine
comp185333_c1 T-cell receptor
alpha chain
22.69 2.14 E-10 21.44 4.75 E-3 22.07 2.14 E-5
comp100948_c0 T-cell receptor
alpha chain
24.20 4.44 E-8 23.29 2.15 E-6
comp136812_c0 T-cell receptor
alpha chain
23.07 1.71 E-7 22.86 9.98 E-5
comp183357_c0 T-cell receptor
alpha chain
v region
22.73 1.48 E-15 21.96 1.15 E-4
comp186997_c2 T-cell receptor
beta
+3.21 1.80 E-7 22.76 3.79 E-14 21.61 1.93 E-3
comp193946_c0 T-cell receptor
beta variable
19
22.96 5.05 E-8 22.34 9.66 E-5
comp153538_c0 T-cell receptor
beta chain
23.41 3.89 E-11 22.43 6.85 E-5
comp151427_c0 T-cell receptor
beta chain
23.24 4.78 E-10 21.75 1.52 E-3
comp137067_c0 T-cell receptor
beta chain
23.24 4.68 E-12 22.27 4.92 E-5
comp167921_c0 T-cell receptor
beta chain
22.94 2.87 E-10 21.98 1.37 E-3
comp153207_c0 T-cell receptor
beta chain
22.90 2.12 E-7
comp164781_c0 T-cell receptor
beta chain
22.89 1.47 E-12 22.04 1.23 E-3
comp100980_c0 T-cell receptor
beta chain
22.86 2.99 E-8 21.79 4.20 E-3
comp148731_c0 T-cell receptor
beta chain
22.69 3.49 E-6 22.10 1.54 E-3
comp172614_c0 T-cell receptor
delta chain
+2.00 4.30 E-6
comp180632_c0 T-cell receptor
delta chain
22.24 4.79 E-10 21.00 1.03 E-2
comp176041_c0 T-cell receptor
gamma chain
23.74 8.57 E-12 24.27 2.28 E-10
comp178628_c0 T-cell receptor
gamma chain
21.82 5.20 E-4 21.63 5.76 E-3
comp159481_c0 CD3e epsilon
(CD3-TCR
complex)
+3.57 4.96 E-10 21.78 1.68 E-7 21.52 4.46 E-4
comp185118_c0 CD4 precursor +2.00 8.73 E-5 22.1 2.61 E-8 +1.51 0.001 21.50 2.51 E-3
comp171746_c0 CD8 alpha 22.89 1.67 E-8 21.87 6.89 E-4
comp180074_c0 CD8 beta +0.87 4.55 E-2
Comparisons between uninfected (control) and infected (naïve vs. control and survived vs. control) Atelopus zeteki. P values after FDR correction for multiple tests.
Signiﬁcant decreases in expression are highlighted in bold. FDR, false-discovery rate.
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2012). Infected A. zeteki exhibited increased expression in seven TLR
genes, such as TLR2 and TLR5, in at least one of the three tissues
studied. Importantly TLR2, expressed by a variety of leukocytes, is
known (at least in mammals) to recognize fungal pathogens and
mediates pro-inﬂammatory responses (Goodridge and Underhill
2008). Curiously, TLR5 had the greatest increase in expression in all
tissues, particularly in the skin of naïve-infected frogs. TLR5 is the
only protein-binding receptor highly conserved across vertebrates
from ﬁsh to mammals (Yoon et al. 2012) and only recognizes the
protein ﬂagellin of ﬂagellated bacteria (Hayashi et al. 2001). This result
indicates that naïve-infected animals were possibly responding to in-
creased secondary bacterial infections during the course of Bd infec-
tion. Secondary bacterial infections have been linked to mortality
during fungal infections in amphibians (Taylor et al. 1999). However,
the possibility that this contributes to mortality in Bd-infected am-
phibians remains untested.
A great deal of work on innate amphibian resistance to Bd has
focused on skin AMPs (Conlon 2011b; Voyles et al. 2011). However,
we found no such sequences within our de novo assembly of A. zeteki.
Previous studies have failed to characterize AMPs in other experi-
ments using toads (Family Bufonidae) (Conlon 2011a) and in other
species AMPs are only expressed at an early stage of infection (Ribas
et al. 2009); therefore, our results corroborate that signiﬁcant variation
exists among species in the expression and use of AMPs against Bd
infection.
Perhaps the most striking gene expression increase in infected in-
dividuals was the chitinase CHIT1, a key enzyme for the degradation of
fungal cell walls. Increased expression of this gene was found in both
infection groups compared to controls. However, CHIT1 expression
was signiﬁcantly greater in the spleens of survived-infected than naïve-
infected frogs (with a similar but nonsigniﬁcant trend in the skin). In
fact, CHIT1 exhibited one of the greatest expression changes of all genes
in the spleen of survived-infected individuals. The greater expression
levels observed in frogs previously exposed to Bd suggests some form of
acquired or primed response in the expression of chitinase. Moreover,
in vitro studies by Fites et al. (2013) demonstrate the immunosuppres-
sive activity of Bd may be cell wall derived. Their results, coupled with
our ﬁndings, indicate there may be important coevolutionary dynamics
between Bd cytotoxicity and amphibian host chitinase activity that
warrant further investigation.
Signiﬁcant acquired immune gene expression in
response to Bd infection
The ability of amphibians to develop speciﬁc acquired immune
responses to Bd is still debated (Richmond et al. 2009; Voyles et al.
2011). On the one hand, certain species increase antibody production
after being inoculated with heat-killed Bd (Ramsey et al. 2010), frogs
show increased survival time upon re-infection after previous expo-
sure (Murphy et al. 2011), and speciﬁc MHC class II alleles can confer
increased survival (Savage and Zamudio 2011). In contrast, immuni-
zation trials have been generally unsuccessful (Rollins-Smith et al.
2009; Stice and Briggs 2010), and in transcriptional studies in other
susceptible species investigators found no or very few changes in
expression of genes related to acquired immunity in other species
(Rosenblum et al. 2009, 2012). In this study, we found a suite of genes
with increased expression in infected A. zeteki directly related to
acquired immune responses. Genes encoding B-cell2speciﬁc proteins
and receptors, T-cell markers, and T-cell receptor components were
all found to have increased expression in the skin and intestine of both
infected groups. In addition, both class I and II MHC genes showed
signiﬁcantly increased expression in both naïve-infected and survived-
infected skin samples compared with uninfected controls. Taken
together, these ﬁndings indicate substantial activation of acquired im-
mune pathways in the skin of Bd-infected frogs. Moreover, increased
immunoglobulin expression was observed in all three tissues of
infected frogs. In the skin, some immunoglobulin genes exhibited
signiﬁcant elevation in survived-infected frogs compared with unin-
fected individuals but not in naïve-infected vs. uninfected compari-
sons, suggestive of a memory response at the site of infection in
individuals that were previously Bd exposed.
Species differences in immune responses
Previous transcriptome studies of responses to Bd infection in three
frog species (Silurana tropicalis, Rana mucosa, and Rana sierrae) were
consistent with our ﬁndings that Bd appears to inﬂuence skin integrity
and water/ion balance (Rosenblum et al. 2009, 2012). However, both
studies propose there is an inconsistent or lack of robust immune
response in these susceptible species. Our results clearly contradict
these ﬁndings; we found signiﬁcant increases in expression of all
major immune pathways in a species highly susceptible to chytridio-
mycosis. Moreover, speciﬁc differences included increased expression
of TLR genes (none found previously), complement genes (decreased
in prior studies), and many acquired immune genes (none or few
found in other species). Although it is possible that other susceptible
species have weak immune responses to Bd, it is also possible that
these contrasting ﬁndings are due to the greater sensitivity of RNA-
Seq gene expression analyses over microarray-based experiments used
in prior studies (Marioni et al. 2008; Wang et al. 2009). In addition,
contrasting immune responses to Bd may result from: (1) underlying
interspeciﬁc host differences in immune gene expression (Whitehead
and Crawford 2006), (2) different Bd strains used in experiments
(Berger et al. 2005b; Fisher et al. 2009a), (3) different experimental
temperatures (Andre et al. 2008; Stevenson et al. 2013), (4) different
numbers of zoospores inoculated (.1,000,000 vs. 30,000), and (5)
timing of collection of tissue samples (72-hr or 10221 d in S. tropicalis
Figure 4 Differential gene expression of immunoglobulin heavy chain
constant region in Atelopus zeteki. Results of exact tests for expression
differences, measured by fragments per kilobases per million mapped
(FPKM) in immunoglobulin heavy chain constant region in three tissues
of Atelopus zeteki. Letters indicate signiﬁcant differences among treat-
ment groups (no signiﬁcant difference among groups with same letter,
FDR corrected P value ,0.05) and error bars represent 6 1 SE.
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and 3 or 16 d in Rana sp.). Further work to characterize gene expres-
sion within species across a range of conditions (e.g., temperature, Bd
strain, zoospore dose) and across multiple species using controlled
experimental conditions will allow us to fully elucidate the mecha-
nisms underpinning species differences in immune response to Bd
infection. In addition, important gene expression differences found
in such studies will also warrant validation via qPCR, which remains
the “gold-standard” method for measuring gene expression.
In vivo indicators of immune suppression by
Batrachochytrium dendrobatidis
Although Bd clearly elicits an extensive immunological response at the
transcriptional level in A. zeteki, this species is still highly susceptible.
In our experiment, all infected individuals, even those that previously
survived Bd infection, succumbed to chytridiomycosis (i.e., clinical
signs of disease progressed to loss of righting reﬂex). This ﬁnding
suggests that these substantial immunogenetic changes are insufﬁcient
to survive infection by the Bd.
A potential mechanism for the failure of immune responses to
clear infection could be that Bd elicits the “wrong” immune response,
i.e., immune or inﬂammatory pathways that are activated are ineffec-
tive against the chytrid pathogen, as is seen in some chronic infections
(Ferrero 1997; Zajac et al. 1998). Alternatively, susceptibility may be
simply a problem of magnitude; frogs are mounting immune
responses, but at a level insufﬁcient to tackle infections. Finally, the
time to death by Bd in this susceptible species could be insufﬁcient for
mounting a substantial antibody response; however, experimentally
infected individuals survived 22233 d postinoculation and antibody
production in frogs is typically at a maximum around 14 days under
optimal conditions (Du Pasquier et al. 1989; Maniero et al. 2006;
Marchalonis 1971; Ramsey et al. 2010). In addition, resistant individ-
uals begin to clear Bd infection after 14230 days (Ramsey et al. 2010;
Savage and Zamudio 2011); therefore, insufﬁcient time to mount an
antibody defense seems an unlikely explanation for host susceptibility
in this case. However, as antibody response times are uncharacterized
in this species, the possibility cannot be deﬁnitively ruled out with our
data.
A ﬁnal plausible explanation is that Bd is capable of evading or
suppressing immune functions in susceptible species (Ribas et al.
2009; Rollins-Smith et al. 2011; Rosenblum et al. 2008, 2009). Fites
et al. (2013) provided the ﬁrst evidence for this hypothesis, demon-
strating Bd inhibition of host lymphocyte proliferation. We found
B-cell2related genes, T-cell markers, and many T-cell receptor com-
ponents (including alpha, beta, delta, and gamma chains) have lower
expression in infected frogs than uninfected individuals. Given that
tissues were sampled in the late stages of infection, this could be
a result of cell migration/localization to the skin. However, we found
nowhere near as comprehensive a set of genes with increased expres-
sion in infected skin samples. Alternatively, the strong proinﬂamma-
tory responses observed may actually be dampening lymphocyte
production as is seen during both acute and chronic inﬂammation
in mammals (Gabrilovich and Nagaraj 2009; Hotchkiss et al. 2009).
Decreased gene expression alone cannot discern between patho-
gen- and host-mediated down-regulation of lymphocytes; however,
these results correlate with recent ﬁndings in vitro that show Bd
inhibits splenic lymphocyte proliferation (Fites et al. 2013). Our data
are the ﬁrst in vivo indication that Bd may actually be suppressing
B- and T-cell production, differentiation, and/or maturation in the
spleen. Although not directly quantiﬁed, we also observed that spleen
volume in infected frogs was reduced compared with uninfected indi-
viduals, a condition that is indicative of immune suppression, because
spleen volume is generally increased in vertebrates responding to
infections (Brown and Brown 2002; Vicente et al. 2007). Fites et al.
(2013) also demonstrated Bd induces apoptosis, which could account
for our qualitative observation.
Mechanisms of fungal immunosuppression include the exploita-
tion of host immune-related receptors (Brandhorst et al. 2004) and
the release of toxins (Bondy and Pestka 2000). Bd may produce toxic
factors (McMahon et al. 2013) that inhibit immune responses in vitro,
and these factors may be derived from the fungal cell wall (Fites et al.
2013). Although these cannot be tested with our data, both warrant
further in vivo investigation in terms of Bd activity. In other cases, it
seems fungi can elicit ineffective host responses to infection, which
can actually lead to immunosuppression. For example, Paracocci-
dioides brasiliensis attracts regulatory T cells (Tregs) to sites of infec-
tion, leading to down-modulation of effector immune responses and
the long-term presence of the fungus in granulomas (Moreira et al.
2008). Migration of Tregs is commonly associated with chemokine
receptor 4 (CCR4) and Treg inﬁltration into secondary lymph tissues,
via CCL19, leads to suppression of both B and T cells (Mailloux and
Young 2010). In addition, Tregs often express IL-10 at sites of infec-
tion/inﬂammation, which can minimize host tissue damage but also
allows parasites or viruses to evade effector responses and proliferate
(Belkaid et al. 2006). In our study CCR4, CCL19, and IL-10 all had
signiﬁcantly increased expression in infected frogs. Taken together,
with the observed decreases in expression of T- and B-cell2speciﬁc
genes in the spleen, the possibility that Bd activation of Treg, may
contribute to immune suppression is a promising line of inquiry for
our understanding of the outcome of chytridiomycosis in hosts with
differing susceptibility.
Despite the high susceptibility of Atelopus zeteki to chytridiomy-
cosis, we found wide-ranging and robust immune responses to exper-
imental Bd infections. Our study provides a detailed overview of
immunogenetic changes in response to the fungal pathogen including
increased expression of many innate immune and inﬂammatory path-
ways and adaptive immune genes such as immunoglobulins and
MHC. Moreover, genes thought to be essential to antifungal activity,
such as chitinase and serine-type proteases, exhibited greater expres-
sion in animals previously exposed to Bd, indicating that this species
may mount acquired immune responses to Bd.
We propose that susceptibility to chytridiomycosis in this case is
not necessarily due to lack of acquired immune responses, but instead
is caused by some failure in the efﬁcacy of the responses. Although
ineffective immune pathway activation or insufﬁcient levels of im-
mune effectors cannot be ruled out, the reduced expression levels
of B- and T-cell genes in the spleen of infected animals compared with
controls suggest immunosuppression by the pathogen itself, reinforc-
ing recent ﬁndings of in vitro studies. Our results provide important
in-depth transcriptomic resources for future studies of Bd susceptibil-
ity and anti-Bd amphibian immune mechanisms. In addition, we
highlight the need for transcriptomic studies on highly resistant frog
species to further disentangle potential mechanisms of chytridiomy-
cosis susceptibility.
ACKNOWLEDGMENTS
We thank Vicky Poole and Kevin Murphy of Project Golden Frog and
the Maryland Zoo in Baltimore for help in obtaining surplus Atelopus
zeteki for research; Steven Bogdanowicz and Jennifer Mosher for ad-
vice on Illumina library preparation; Brian Gratwicke for photo-
graphy; and Brian Lazzaro and Zamudio Lab members for their
constructive comments. This study was supported by grants from
the National Science Foundation (DEB-0815315 and DEB-1120249),
1286 | A. R. Ellison et al.
the Cornell Center for Vertebrate Genomics, and Cornell’s Atkinson
Center for Sustainable Future.
LITERATURE CITED
Akdis, M., S. Burgler, R. Crameri, T. Eiwegger, H. Fujita et al.,
2011 Interleukins, from 1 to 37, and interferon-g: receptors, functions,
and roles in diseases. J. Allergy Clin. Immunol. 127: 701–721.e770.
Altizer, S., R. Bartel, and B. A. Han, 2011 Animal migration and infectious
disease risk. Science 331: 296–302.
Andre, S. E., J. Parker, and C. J. Briggs, 2008 Effect of temperature on host
response to Batrachochytrium dendrobatidis infection in the mountain
yellow-legged frog (Rana muscosa). J. Wildl. Dis. 44: 716–720.
Andrews, S., 2010 FastQC. A quality control tool for high throughput
sequence data. Babraham Bioinformatics. Available at: http://www.bio-
informatics.babraham.ac.uk/projects/fastqc/. Accessed May 21, 2014.
Belkaid, Y., R. B. Blank, and I. Sufﬁa, 2006 Natural regulatory T cells and
parasites: a common quest for host homeostasis. Immunol. Rev. 212:
287–300.
Berger, L., R. Speare, P. Daszak, D. E. Green, A. A. Cunningham et al.,
1998 Chytridiomycosis causes amphibian mortality associated with
population declines in the rain forests of Australia and Central America.
Proc. Natl. Acad. Sci. USA 95: 9031–9036.
Berger, L., A. D. Hyatt, R. Speare, and J. E. Longcore, 2005a Life cycle stages
of the amphibian chytrid Batrachochytrium dendrobatidis. Dis. Aquat.
Organ. 68: 51–63.
Berger, L., G. Marantelli, L. F. Skerratt, and R. Speare, 2005b Virulence of
the amphibian chytrid fungus Batrachochytrium dendrobatidis varies
with the strain. Dis. Aquat. Organ. 68: 47–50.
Blaustein, A. R., and A. Dobson, 2006 Extinctions: a message from the
frogs. Nature 439: 143–144.
Bondy, G. S., and J. J. Pestka, 2000 Immunomodulation by fungal toxins.
J. Toxicol. Environ. Health B Crit. Rev. 3: 109–143.
Boyle, D. G., D. B. Boyle, V. Olsen, J. A. T. Morgan, and A. D. Hyatt,
2004 Rapid quantitative detection of chytridiomycosis (Batrachochy-
trium dendrobatidis) in amphibian samples using real-time Taqman PCR
assay. Dis. Aquat. Organ. 60: 141–148.
Brandhorst, T. T., M. Wüthrich, B. Finkel-Jimenez, T. Warner, and B. S.
Klein, 2004 Exploiting type 3 complement receptor for TNF-a sup-
pression, immune evasion, and progressive pulmonary fungal infection.
J. Immunol. 173: 7444–7453.
Brem, F. M. R., and K. R. Lips, 2008 Batrachochytrium dendrobatidis in-
fection patterns among Panamanian amphibian species, habitats and
elevations during epizootic and enzootic stages. Dis. Aquat. Organ. 81:
189–202.
Briggs, C. J., R. A. Knapp, and V. T. Vredenburg, 2010 Enzootic and epi-
zootic dynamics of the chytrid fungal pathogen of amphibians. Proc. Natl.
Acad. Sci. USA 107: 9695–9700.
Brown, C. R., and M. B. Brown, 2002 Spleen volume varies with colony size
and parasite load in a colonial bird. Proc. R. Soc. Lond. B Biol. Sci. 269:
1367–1373.
Carey, C., J. E. Bruzgul, L. J. Livo, M. L. Walling, K. A. Kuehl et al.,
2006 Experimental exposures of boreal toads (Bufo boreas) to a patho-
genic chytrid fungus (Batrachochytrium dendrobatidis). EcoHealth 3:
5–21.
Cashins, S. D., L. F. Grogan, M. McFadden, D. Hunter, P. S. Harlow et al.,
2013 Prior infection does not improve survival against the amphibian
disease chytridiomycosis. PLoS One 8: e56747.
Chomel, B. B., A. Belotto, and F.-X. Meslin, 2007 Wildlife, exotic pets, and
emerging zoonoses. Emerg. Infect. Dis. 13: 6.
Conlon, J. M., 2011a Structural diversity and species distribution of host-
defense peptides in frog skin secretions. Cell. Mol. Life Sci. 68: 2303–2315.
Conlon, J. M., 2011b The contribution of skin antimicrobial peptides to the
system of innate immunity in anurans. Cell Tissue Res. 343: 201–212.
Cronin, J. P., M. E. Welsh, M. G. Dekkers, S. T. Abercrombie, and C. E.
Mitchell, 2010 Host physiological phenotype explains pathogen reser-
voir potential. Ecol. Lett. 13: 1221–1232.
Daszak, P., A. A. Cunningham, and A. D. Hyatt, 2000 Emerging infectious
diseases of wildlife—threats to biodiversity and human health. Science
287: 443–449.
de Vries, J. E., 1995 Immunosuppressive and anti-inﬂammatory properties
of interleukin 10. Ann. Med. 27: 537–541.
Dobson, A., 2004 Population dynamics of pathogens with multiple host
species. Am. Nat. 164: S64–S78.
Duellman, W. E., 1999 Patterns of Distribution of Amphibians: A Global
Perspective. JHU Press, Baltimore, MD.
Du Pasquier, L., J. Schwager, and M. F. Flajnik, 1989 The immune system
of Xenopus. Annu. Rev. Immunol. 7: 251–275.
Farrer, R. A., L. A. Weinert, J. Bielby, T. W. J. Garner, F. Balloux et al.,
2011 Multiple emergences of genetically diverse amphibian-infecting
chytrids include a globalized hypervirulent recombinant lineage. Proc.
Natl. Acad. Sci. USA 108: 18732–18736.
Ferrero, R. L., 1997 Immune responses to mucosal infection: the Helico-
bacter pylori paradigm. Res. Immunol. 148: 91–107.
Fisher, M. C., J. Bosch, Z. Yin, D. A. Stead, J. Walker et al., 2009a Proteomic and
phenotypic proﬁling of the amphibian pathogen Batrachochytrium dendro-
batidis shows that genotype is linked to virulence. Mol. Ecol. 18: 415–429.
Fisher, M. C., T. W. Garner, and S. F. Walker, 2009b Global emergence of
Batrachochytrium dendrobatidis and amphibian chytridiomycosis in
space, time, and host. Annu. Rev. Microbiol. 63: 291–310.
Fisher, M. C., D. A. Henk, C. J. Briggs, J. S. Brownstein, L. C. Madoff et al.,
2012 Emerging fungal threats to animal, plant and ecosystem health.
Nature 484: 186–194.
Fites, J. S., J. P. Ramsey, W. M. Holden, S. P. Collier, D. M. Sutherland et al.,
2013 The invasive chytrid fungus of amphibians paralyzes lymphocyte
responses. Science 342: 366–369.
Gabrilovich, D. I., and S. Nagaraj, 2009 Myeloid-derived suppressor cells as
regulators of the immune system. Nat. Rev. Immunol. 9: 162–174.
Gewin, V., 2008 Riders of a modern-day ark. PLoS Biol. 6: e24.
Goodridge, H., and D. Underhill, 2008 Fungal recognition by TLR2 and
Dectin-1, pp. 87–109 in Toll-Like Receptors (TLRs) and Innate Immunity,
edited by S. Bauer, and G. Hartmann. Springer-Verlag, Berlin.
Gorman, M. J., and S. M. Paskewitz, 2001 Serine proteases as mediators of
mosquito immune responses. Insect Biochem. Mol. Biol. 31: 257–262.
Grabherr, M. G., B. J. Haas, M. Yassour, J. Z. Levin, D. A. Thompson et al.,
2011 Full-length transcriptome assembly from RNA-Seq data without
a reference genome. Nat. Biotechnol. 29: 644–652.
Graham, A. L., J. E. Allen, and A. F. Read, 2005 Evolutionary causes and
consequences of immunopathology. Annu. Rev. Ecol. Evol. Syst. 36: 373–397.
Hansen, K. D., Z. Wu, R. A. Irizarry, and J. T. Leek, 2011 Sequencing
technology does not eliminate biological variability. Nat. Biotechnol. 29:
572–573.
Harrison, P. W., J. E. Mank, and N. Wedell, 2012 Incomplete sex chro-
mosome dosage compensation in the Indian Meal Moth, Plodia inter-
punctella, based on de novo transcriptome assembly. Genome Biol. Evol.
4: 1118–1126.
Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi et al., 2001 The
innate immune response to bacterial ﬂagellin is mediated by Toll-like
receptor 5. Nature 410: 1099–1103.
Haydon, D. T., S. Cleaveland, L. H. Taylor, and M. K. Laurenson,
2002 Identifying reservoirs of infection: a conceptual and practical
challenge. Emerg. Infect. Dis. 8: 1468–1473.
Homey, B., H. Alenius, A. Muller, H. Soto, E. P. Bowman et al.,
2002 CCL27–CCR10 interactions regulate T cell-mediated skin in-
ﬂammation. Nat. Med. 8: 157–165.
Hotchkiss, R. S., C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson,
2009 The sepsis seesaw: tilting toward immunosuppression. Nat. Med.
15: 496–497.
Hung, C.-Y., K. R. Seshan, J.-J. Yu, R. Schaller, J. Xue et al., 2005 A met-
alloproteinase of Coccidioides posadasii contributes to evasion of host
detection. Infect. Immun. 73: 6689–6703.
Hyatt, A. D., D. G. Boyle, V. Olsen, D. B. Boyle, L. Berger et al.,
2007 Diagnostic assays and sampling protocols for the detection of
Batrachochytrium dendrobatidis. Dis. Aquat. Organ. 73: 175–192.
Volume 4 July 2014 | Transcriptomic Responses to Chytridiomycosis | 1287
Jones, K. E., N. G. Patel, M. A. Levy, A. Storeygard, D. Balk et al., 2008 Global
trends in emerging infectious diseases. Nature 451: 990–993.
Kolls, J. K., and A. Lindén, 2004 Interleukin-17 family members and in-
ﬂammation. Immunity 21: 467–476.
Kriger, K. M., H. B. Hines, A. D. Hyatt, D. G. Boyle, and J.-M. Hero,
2006 Techniques for detecting chytridiomycosis in wild frogs: com-
paring histology with real-time Taqman PCR. Dis. Aquat. Organ. 71: 141.
Langhammer, P., K. Lips, P. Burrowes, T. Tunstall, C. Palmer et al., 2013 A
fungal pathogen of amphibians, Batrachochytrium dendrobatidis, at-
tenuates in pathogenicity with in vitro passages. PLoS One 8: e77630.
Lips, K. R., 1999 Mass mortality and population declines of Anurans at an
upland site in Western Panama. Conserv. Biol. 13: 117–125.
Lips, K. R., F. Brem, R. Brenes, J. D. Reeve, R. A. Alford et al.,
2006 Emerging infectious disease and the loss of biodiversity in a Neo-
tropical amphibian community. Proc. Natl. Acad. Sci. USA 103: 3165–
3170.
Lohse, M., A. M. Bolger, A. Nagel, A. R. Fernie, J. E. Lunn et al.,
2012 RobiNA: a user-friendly, integrated software solution for RNA-
Seq-based transcriptomics. Nucleic Acids Res. 40: W622–W627.
Longcore, J. E., A. P. Pessier, and D. K. Nichols, 1999 Batrachochytrium
dendrobatidis gen. et sp. nov., a chytrid pathogenic to amphibians.
Mycologia 91: 219–227.
Luther, K., and F. Ebel, 2006 Toll-like receptors: recent advances, open
questions and implications for aspergillosis control. Med. Mycol. 44: 219–
227.
Mailloux, A., and M. R. I. Young, 2010 Regulatory T-cell trafﬁcking: from
thymic development to tumor-induced immune suppression. Crit. Rev.
Immunol. 30: 435–447.
Maniero, G. D., H. Morales, J. Gantress, and J. Robert, 2006 Generation of
a long-lasting, protective, and neutralizing antibody response to the ra-
navirus FV3 by the frog Xenopus. Dev. Comp. Immunol. 30: 649–657.
Marchalonis, J. J., 1971 Immunoglobulins and antibody-production in
amphibians. Am. Zool. 11: 171–181.
Marioni, J. C., C. E. Mason, S. M. Mane, M. Stephens, and Y. Gilad,
2008 RNA-seq: an assessment of technical reproducibility and com-
parison with gene expression arrays. Genome Res. 18: 1509–1517.
McKerrow, J. H., C. Caffrey, B. Kelly, P. n. Loke, and M. Sajid,
2006 Proteases in parasitic diseases. Annu. Rev. Pathol. 1: 497–536.
McMahon, T. A., L. A. Brannelly, M. W. H. Chatﬁeld, P. T. J. Johnson, M. B.
Joseph et al., 2013 Chytrid fungus Batrachochytrium dendrobatidis has
nonamphibian hosts and releases chemicals that cause pathology in the
absence of infection. Proc. Natl. Acad. Sci. USA 110: 210–215.
Moghadam, H. K., P. W. Harrison, G. Zachar, T. Székely, and J. E. Mank,
2013 The plover neurotranscriptome assembly: transcriptomic analysis
in an ecological model species without a reference genome. Mol. Ecol.
Res. 13: 696–705.
Moreira, A. P., K. A. Cavassani, F. S. M. Tristão, A. P. Campanelli, R.
Martinez et al., 2008 CCR5-dependent regulatory T cell migration me-
diates fungal survival and severe immunosuppression. J. Immunol. 180:
3049–3056.
Murphy, P. J., S. St-Hilaire, and P. S. Corn, 2011 Temperature, hydric
environment, and prior pathogen exposure alter the experimental severity
of chytridiomycosis in boreal toads. Dis. Aquat. Organ. 95: 31–42.
Mußmann, R., L. Du Pasquier, and E. Hsu, 1996 Is Xenopus IgX an analog
of IgA? Eur. J. Immunol. 26: 2823–2830.
Myhre, S., H. Tveit, T. Mollestad, and A. Lægreid, 2006 Additional Gene
Ontology structure for improved biological reasoning. Bioinformatics 22:
2020–2027.
Nichols, D. K., E. W. Lamirande, A. P. Pessier, and J. E. Longcore,
2001 Experimental transmission of cutaneous chytridiomycosis in
dendrobatid frogs. J. Wildl. Dis. 37: 1–11.
Ohta, Y., W. Goetz, M. Z. Hossain, M. Nonaka, and M. F. Flajnik,
2006 Ancestral organization of the MHC revealed in the amphibian
Xenopus. J. Immunol. 176: 3674–3685.
Page, G., J. Edwards, G. Gadbury, P. Yelisetti, J. Wang et al., 2006 The
PowerAtlas: a power and sample size atlas for microarray experimental
design and research. BMC Bioinf. 7: 84.
Pham, C. T. N., 2006 Neutrophil serine proteases: speciﬁc regulators of
inﬂammation. Nat. Rev. Immunol. 6: 541–550.
Quevillon, E., V. Silventoinen, S. Pillai, N. Harte, N. Mulder et al.,
2005 InterProScan: protein domains identiﬁer. Nucleic Acids Res. 33:
W116–W120.
Ramsey, J. P., L. K. Reinert, L. K. Harper, D. C. Woodhams, and L. A. Rollins-
Smith, 2010 Immune defenses against Batrachochytrium dendrobatidis,
a fungus linked to global amphibian declines, in the South African
Clawed Frog, Xenopus laevis. Infect. Immun. 78: 3981–3992.
Ribas, L., M.-S. Li, B. J. Doddington, J. Robert, J. A. Seidel et al.,
2009 Expression proﬁling the temperature-dependent amphibian response
to infection by Batrachochytrium dendrobatidis. PLoS ONE 4: e8408.
Richmond, J. Q., A. E. Savage, K. R. Zamudio, and E. B. Rosenblum,
2009 Toward immunogenetic studies of amphibian chytridiomycosis:
linking innate and acquired immunity. Bioscience 59: 311–320.
Robinson, M. D., D. J. McCarthy, and G. K. Smyth, 2010 edgeR: a Bio-
conductor package for differential expression analysis of digital gene
expression data. Bioinformatics 26: 139–140.
Roeder, A., C. J. Kirschning, R. A. Rupec, M. Schaller, G. Weindl et al.,
2004 Toll-like receptors as key mediators in innate antifungal immu-
nity. Med. Mycol. 42: 485–498.
Rollins-Smith, L. A., C. Carey, J. Longcore, J. K. Doersam, A. Boutte et al.,
2002 Activity of antimicrobial skin peptides from ranid frogs against
Batrachochytrium dendrobatidis, the chytrid fungus associated with
global amphibian declines. Dev. Comp. Immunol. 26: 471–479.
Rollins-Smith, L. A., J. P. Ramsey, L. K. Reinert, D. C. Woodhams, L. J. Livo
et al., 2009 Immune defenses of Xenopus laevis against Batrachochy-
trium dendrobatidis. Front. Biosci. 1: 68–91.
Rollins-Smith, L. A., J. P. Ramsey, J. D. Pask, L. K. Reinert, and D. C.
Woodhams, 2011 Amphibian immune defenses against chytridiomycosis:
impacts of changing environments. Integr. Comp. Biol. 51: 552–562.
Rosenblum, E. B., J. E. Stajich, N. Maddox, and M. B. Eisen, 2008 Global
gene expression proﬁles for life stages of the deadly amphibian pathogen
Batrachochytrium dendrobatidis. Proc. Natl. Acad. Sci. USA 105: 17034–
17039.
Rosenblum, E. B., T. J. Poorten, M. Settles, G. K. Murdoch, J. Robert et al.,
2009 Genome-wide transcriptional response of Silurana (Xenopus)
tropicalis to infection with the deadly chytrid fungus. PLoS ONE 4: e6494.
Rosenblum, E. B., T. J. Poorten, M. Settles, and G. K. Murdoch, 2012 Only
skin deep: shared genetic response to the deadly chytrid fungus in sus-
ceptible frog species. Mol. Ecol. 21: 3110–3120.
Rousset, F., E. Garcia, T. Defrance, C. Péronne, N. Vezzio et al.,
1992 Interleukin 10 is a potent growth and differentiation factor for
activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890–1893.
Savage, A. E., and K. R. Zamudio, 2011 MHC genotypes associate with
resistance to a frog-killing fungus. Proc. Natl. Acad. Sci. USA 108: 16705–
16710.
Sears, B. F., J. R. Rohr, J. E. Allen, and L. B. Martin, 2011 The economy of
inﬂammation: when is less more? Trends Parasitol. 27: 382–387.
Skerratt, L., L. Berger, R. Speare, S. Cashins, K. McDonald et al.,
2007 Spread of chytridiomycosis has caused the rapid global decline
and extinction of frogs. EcoHealth 4: 125–134.
Smith, K. F., K. Acevedo-Whitehouse, and A. B. Pedersen, 2009 The role of
infectious diseases in biological conservation. Anim. Conserv. 12: 1–12.
Steinhoff, M., J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann et al.,
2005 Proteinase-activated receptors: transducers of proteinase-mediated
signaling in inﬂammation and immune response. Endocr. Rev. 26: 1–43.
Stevenson, L. A., R. A. Alford, S. C. Bell, E. A. Roznik, L. Berger et al.,
2013 Variation in thermal performance of a widespread pathogen, the
amphibian chytrid fungus Batrachochytrium dendrobatidis. PLoS ONE 8:
e73830.
Stice, M. J., and C. J. Briggs, 2010 Immunization is ineffective at preventing
infection and mortality due to the amphibian chytrid fungus Batracho-
chytrium dendrobatidis. J. Wildl. Dis. 46: 70–77.
Stranger, B. E., M. S. Forrest, M. Dunning, C. E. Ingle, C. Beazley et al.,
2007 Relative impact of nucleotide and copy number variation on gene
expression phenotypes. Science 315: 848–853.
1288 | A. R. Ellison et al.
Taylor, S. K., E. S. Williams, E. T. Thorne, K. W. Mills, D. I. Withers et al.,
1999 Causes of mortality of the Wyoming toad. J. Wildl. Dis. 35: 49–57.
Tischendorf, F., 1985 On the evolution of the spleen. Experientia 41:
145–152.
Vicente, J., L. Pérez-Rodríguez, and C. Gortazar, 2007 Sex, age, spleen size,
and kidney fat of red deer relative to infection intensities of the lungworm
Elaphostrongylus cervi. Naturwissenschaften 94: 581–587.
Voyles, J., S. Young, L. Berger, C. Campbell, W. F. Voyles et al.,
2009 Pathogenesis of chytridiomycosis, a cause of catastrophic am-
phibian declines. Science 326: 582–585.
Voyles, J., E. B. Rosenblum, and L. Berger, 2011 Interactions between
Batrachochytrium dendrobatidis and its amphibian hosts: a review of
pathogenesis and immunity. Microbes Infect. 13: 25–32.
Wang, Z., M. Gerstein, and M. Snyder, 2009 RNA-Seq: a revolutionary tool
for transcriptomics. Nat. Rev. Genet. 10: 57–63.
Whitehead, A., and D. L. Crawford, 2006 Variation within and among
species in gene expression: raw material for evolution. Mol. Ecol. 15:
1197–1211.
Woodhams, D. C., and R. A. Alford, 2005 Ecology of chytridiomycosis in
rainforest stream frog assemblages of tropical Queensland. Conserv. Biol.
19: 1449–1459.
Woodhams, D. C., K. Ardipradja, R. A. Alford, G. Marantelli, L. K. Reinert
et al., 2007 Resistance to chytridiomycosis varies among amphibian
species and is correlated with skin peptide defenses. Anim. Conserv. 10:
409–417.
Woods, J. P., 2003 Knocking on the right door and making a comfortable
home: Histoplasma capsulatum intracellular pathogenesis. Curr. Opin.
Microbiol. 6: 327–331.
Yoon, S.-i., O. Kurnasov, V. Natarajan, M. Hong, A. V. Gudkov et al.,
2012 Structural basis of TLR5-ﬂagellin recognition and signaling. Sci-
ence 335: 859–864.
Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh
et al., 1998 Viral immune evasion due to persistence of activated T cells
without effector function. J. Exp. Med. 188: 2205–2213.
Communicating editor: D. Schneider
Volume 4 July 2014 | Transcriptomic Responses to Chytridiomycosis | 1289
